Results 71 to 80 of about 1,334 (146)

One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration

Ophthalmology and Therapy
Introduction This study assessed the efficacy, durability, and safety of faricimab in patients with neovascular age-related macular degeneration (nAMD), previously treated with aflibercept or ranibizumab with unsatisfactory results.
Giuseppe Cancian, Arianna Paris, Lia Agliati, Angelica Rizzato, Michele Clerici, Giulio Volpe, Moreno Menghini, Gabriela Grimaldi   +7 more
doaj   +1 more source

Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration

Clinical Ophthalmology
Abraham Hang, Taylor Ngo, Jaipreet Singh Virk, Kareem Moussa, Ala Moshiri, Parisa Emami-Naeini, Susanna S Park Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USACorrespondence: Susanna S Park ...
Hang A, Ngo T, Virk JS, Moussa K, Moshiri A, Emami-Naeini P, Park SS   +6 more
doaj  

Analysis of Choriocapillaris Reperfusion Topography Following Faricimab Treatment for Neovascular Age-Related Macular Degeneration in Therapy-Naïve Patients

Ophthalmology and Therapy
Introduction To assess changes in choriocapillaris (CC) vascular density surrounding macular neovascularization (MNV) in treatment-naïve age-related macular degeneration (AMD) after faricimab application using optical coherence tomography angiography ...
Max Brinkmann, Pasquale Viggiano, Giacomo Boscia, Tom Müller, Niccolò Castellino, Jakob Schweighofer, Francesco Boscia, Mario Damiano Toro, Yosuf El-Shabrawi   +8 more
doaj   +1 more source

Faricimab: expanding horizon beyond VEGF [PDF]

Eye, 2019
Sharma A., Kumar N., Kuppermann B. D., Bandello F., Loewenstein A.   +4 more
openaire   +4 more sources

Economic Assessment in Resource-Constrained Systems: Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema

Ophthalmology and Therapy
Introduction Cost-effectiveness analyses typically ignore healthcare system resource constraints. Ophthalmology is affected by resource constraints because of increasing disease prevalence and the use of resource-intensive treatments.
Tara Li, Vladislav Berdunov, Robin Hamilton, Yaneth Gil Rojas, Christian Bührer, Oliver Cox, Roelien Postema, Marloes Bagijn   +7 more
doaj   +1 more source

Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases – The FAR-PEARL Study Report 1

Clinical Ophthalmology
Kenneth CS Fong,1 Wilson Jun Jie Wong,1 Hon Seng Wong,1 Kiet Phang Ling,1 Shir-Ning Fong,2 Manoharan Shunmugam1 1OasisEye Specialists, Kuala Lumpur, Kuala Lumpur, Malaysia; 2University of Nottingham Medical School, Nottingham, NG72UH, UKCorrespondence ...
Fong KC, Wong WJJ, Wong HS, Ling KP, Fong SN, Shunmugam M   +5 more
doaj  

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report. [PDF]

BMJ Open Ophthalmol
Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K.   +20 more
europepmc   +1 more source

Intraocular inflammation after intravitreal injection of faricimab-a case series including one case of bilateral choroidal involvement. [PDF]

Int J Ophthalmol
Lischke R, Krause SM, Rauchegger T, Haas G, Koubek M, Nowosielski Y, Rehak M.   +6 more
europepmc   +1 more source

Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration

Clinical Ophthalmology
Asako Tanaka, Masayuki Hata, Memiri Tsuchikawa, Naoko Ueda-Arakawa Ueda-Arakawa, Hiroshi Tamura, Manabu Miyata, Ayako Takahashi, Ai Kido, Yuki Muraoka, Masahiro Miyake, Sotaro Ooto, Akitaka Tsujikawa Department of Ophthalmology and Visual Sciences, Kyoto
Tanaka A, Hata M, Tsuchikawa M, Ueda-Arakawa NUA, Tamura H, Miyata M, Takahashi A, Kido A, Muraoka Y, Miyake M, Ooto S, Tsujikawa A   +11 more
doaj  

Massive Submacular Hemorrhage Following Intravitreal Faricimab Injection for Neovascular Age-Related Macular Degeneration. [PDF]

Cureus
Kaganovski A, Rostomian N, Shrier E.
europepmc   +1 more source